Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy
ConditionDiabetic Neuropathies
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-65
SponsorCairo University
About this trial
This study will be carried out on 60 patients both gender male and female with diabetic neuropathy with age55-65 years. The patients will be selected from Elmahmoudia hospital .patients will be randomly assigned to two groups.
Eligibility criteria
Qualifiers
1. Diagnosis of diabetes based on World Health Organization (WHO) with ages from 55to 65years 2. BMI> 25kg/m2 3. Clinically diagnosed with diabetic neuropathy. 4. All patients are taking oral hypoglycemic drugs with controlled diabetes mellitus.
Disqualifiers
1. Presence of other significant neurological or musculoskeletal disorders that may confound the assessment of outcomes.
Trial design
Treatments tested in this trial
- experimental group
- control group
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov